Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication

被引：9

作者：

Skerlj, Renato ^{[1
]}

Bridger, Gary ^{[2
]}

Zhou, Yuanxi ^{[2
]}

Bourque, Elyse ^{[1
]}

Langille, Jonathan ^{[2
]}

Di Fluri, Maria ^{[2
]}

Bogucki, David ^{[2
]}

Yang, Wen ^{[2
]}

Li, Tongshuang ^{[2
]}

Wang, Letian ^{[2
]}

Nan, Susan ^{[2
]}

Baird, Ian ^{[2
]}

Metz, Markus ^{[1
]}

Darkes, Marilyn ^{[2
]}

Labrecque, Jean ^{[2
]}

Lau, Gloria ^{[1
]}

Fricker, Simon ^{[1
]}

Huskens, Dana ^{[3
]}

Schols, Dominique ^{[3
]}

机构：

[1] Genzyme Corp, Waltham, MA 02451 USA

[2] AnorMED Inc, Langley, BC V2Y 1N5, Canada

[3] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 08期

关键词：

CCR5; Chemokine receptor; HIV-1; Schering C; IMMUNODEFICIENCY-VIRUS TYPE-1; BIOLOGICAL EVALUATION; RECEPTOR; MARAVIROC; AMD3100;

D O I：

10.1016/j.bmcl.2011.02.058

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of CCR5 antagonists were identified based on the redesign of Schering C. An SAR was established based on inhibition of CCR5 (RANTES) binding and these compounds exhibited potent inhibition of R5 HIV-1 replication in peripheral blood mononuclear cells. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：2450 / 2455

页数：6

共 34 条

[21] Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase
Sun, Yixing
Xu, Weisi
Fan, Ningning
Sun, Xuefeng
Ning, Xianling
Ma, Liying
Liu, Junyi
Wang, Xiaowei
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (03) : 1076 - 1084
[22] Synthesis and biological evaluation of 1,3,3,4-tetrasubstituted pyrrolidine CCR5 receptor antagonists. Discovery of a potent and orally bioavailable anti-HIV agent
Ma, Dawei
Yu, Shanghai
Li, Ben
Chen, Li
Chen, Renhai
Yu, Kunqian
Zhang, Linqi
Chen, Zhiwei
Zhong, Dafang
Gong, Zheng
Wang, Renxiao
Jiang, Hualiang
Pei, Gang
CHEMMEDCHEM, 2007, 2 (02) : 187 - 193
[23] Integrated Computational Tools for Identification of CCR5 Antagonists as Potential HIV-1 Entry Inhibitors: Homology Modeling, Virtual Screening, Molecular Dynamics Simulations and 3D QSAR Analysis
Moonsamy, Suri
Dash, Radha Charan
Soliman, Mahmoud E. S.
MOLECULES, 2014, 19 (04): : 5243 - 5265
[24] Orally active CCR5 antagonists as anti-HIV-1 agents 2:: Synthesis and biological activities of anilide derivatives containing a pyridine N-oxide moiety
Seto, M
Aramaki, Y
Imoto, H
Aikawa, K
Oda, T
Kanzaki, N
Iizawa, Y
Baba, M
Shiraishi, M
CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (07) : 818 - 829
[25] Dynamics of memory and naive CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rγnull mice infected with CCR5-tropic HIV-1
Sato, Kei
Nie, Chuanyi
Misawa, Naoko
Tanaka, Yuetsu
Ito, Mamoru
Koyanagi, Yoshio
VACCINE, 2010, 28 : B32 - B37
[26] Design, synthesis and anti-HIV evaluation of 5-alkyl-6-(benzo[d][1,3] dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs
Li, Yi-Ming
Luo, Rong-Hua
Yang, Liu-Meng
Huang, Si-Ming
Li, Sui-Yuan
Zheng, Yu-Gui
Ni, Dong-Xuan
Cui, Yi-Man
Zhang, Xing-Jie
Li, Xiao-Li
Zhang, Rui-Han
Tang, E.
Zhang, Hong-Bin
Zheng, Yong-Tang
He, Yan-Ping
Xiao, Wei-Lie
BIOORGANIC CHEMISTRY, 2020, 102
[27] CCR5 antagonists as anti-HIV-1 agents.: Part 2:: Synthesis and biological evaluation of N-[3-(4-benzylpiperidin-1-yl)propyl]-N,N′-diphenylureas
Imamura, S
Kurasawa, O
Nara, Y
Ichikawa, T
Nishikawa, Y
Iida, T
Hashiguchia, S
Kanzaki, N
Iizawa, Y
Baba, M
Sugihara, Y
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (09) : 2295 - 2306
[28] Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors
Langford, H. Marie
Williams, Peter D.
Homnick, Carl F.
Vacca, Joseph P.
Felock, Peter J.
Stillmock, Kara A.
Witmer, Marc V.
Hazuda, Daria J.
Gabryelski, Lori J.
Schleif, William A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) : 721 - 725
[29] Design, synthesis and biological evaluation of novel 2-(5-aryl-1H-imidazol-1-yl) derivatives as potential inhibitors of the HIV-1 Vpu and host BST-2 protein interaction
Rashamuse, Thompho J.
Njengele, Zikhona
Coyanis, E. Mabel
Sayed, Yasien
Mosebi, Salerwe
Bode, Moira L.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 190
[30] An Imidazopiperidine Series of CCR5 Antagonists for the Treatment of HIV The Discovery of N-{(1S)-1-(3-Fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[321]oct-8-yl]propyl}acetamide (PF-232798)
Stupple, Paul A.
Batchelor, David V.
Corless, Martin
Dorr, Patrick K.
Ellis, David
Fenwick, David R.
Galan, Sebasticn R. G.
Jones, Rhys M.
Mason, Helen J.
Middleton, Donald S.
Perros, Manos
Perruccio, Francesca
Platts, Michelle Y.
Pryde, David C.
Rodrigues, Deborah
Smith, Nicholas N.
Stephenson, Peter T.
Webster, Robert
Westby, Mike
Wood, Anthony
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 67 - 77

← 1 2 3 4 →